Comparative effectiveness of tocilizumab vs standard care in patients with severe COVID-19-related pneumonia: a retrospective cohort study utilizing registry data as a synthetic control

Comparative effectiveness of tocilizumab vs standard care in patients with severe COVID-19-related pneumonia: a retrospective cohort study utilizing registry data as a synthetic control

Abstract Background The severity of coronavirus disease 2019 (COVID-19) infections has led to the development of several therapeutic agents, with tocilizumab becoming increasingly used to treat patients with COVID-19-related pneumonia. This study compared the use of tocilizumab treatment with the st...

Full description

Bibliographic Details
Main Authors: Yukari Uemura, Ryoto Ozaki, Tomohiro Shinozaki, Hiroshi Ohtsu, Yousuke Shimizu, Kazuo Izumi, Sho Saito, Nobuaki Matsunaga, Norio Ohmagari
Format: Article
Language:English
Published: BMC 2023-12-01
Series:BMC Infectious Diseases
Subjects:
Tocilizumab
COVID-19-related pneumonia
Synthetic control
COVID-19 Registry Japan
Online Access:https://doi.org/10.1186/s12879-023-08840-6

Internet

https://doi.org/10.1186/s12879-023-08840-6

Similar Items